Section of Colon and Rectal Surgery

Medicine & Life Sciences

1. Rectal Neoplasms 100%
2. Colorectal Neoplasms 36%
3. Crohn Disease 32%
4. Colonic Neoplasms 28%
5. Colectomy 27%
6. Proctectomy 26%
7. Neoadjuvant Therapy 25%
8. Neoplasms 24%
9. Recurrence 20%
10. Survival 20%
11. Colorectal Surgery 19%
12. Surgeons 19%
13. Colon 18%
14. Radiotherapy 17%
15. Therapeutics 16%
16. Drug Therapy 16%
17. Chemoradiotherapy 15%
18. Adenocarcinoma 14%
19. Inflammatory Bowel Diseases 14%
20. Restorative Proctocolectomy 13%
21. Disease-Free Survival 12%
22. Hereditary Nonpolyposis Colorectal Neoplasms 12%
23. Radiation 12%
24. Quality of Life 11%
25. Fistula 11%
26. Wounds and Injuries 11%
27. Ulcerative Colitis 10%
28. Surgical Wound Infection 10%
29. Ileostomy 10%
30. Liver 9%
31. Adjuvant Chemotherapy 9%
32. Aberrant Crypt Foci 9%
33. Rectum 8%
34. Guidelines 8%
35. Morbidity 8%
36. Laparoscopy 8%
37. Ileal Diseases 8%
38. Deep Learning 8%
39. Anal Canal 8%
40. Practice Guidelines 8%
41. Length of Stay 7%
42. Lymph Nodes 7%
43. Fecal Incontinence 7%
44. Rectal Prolapse 7%
45. Colostomy 7%
46. Ostomy 7%
47. Adenomatous Polyposis Coli 6%
48. Colonic Pouches 6%
49. Swine 6%
50. Multiple Endocrine Neoplasia Type 1 6%
51. Mortality 6%
52. Neoplasm Metastasis 6%
53. Adenoma 6%
54. Genes 6%
55. Quality Improvement 6%
56. Fluorouracil 6%
57. Biopsy 5%
58. Anastomotic Leak 5%
59. Genetic Testing 5%
60. Liver Transplantation 5%
61. Colitis 5%
62. Polyps 5%
63. Rectal Fistula 5%
64. Anatomy 5%
65. Multicenter Studies 5%
66. Curriculum 5%
67. Confidence Intervals 5%
68. Internship and Residency 5%
69. Carcinoid Tumor 5%
70. Pelvis 5%
71. Paneth Cells 5%
72. Optical Coherence Tomography 5%
73. Postoperative Complications 5%
74. vedolizumab 5%